ReJoin(TM), adipose-derived mesenchymal precursor cell for knee osteoarthritis
ReJoin(TM) is a human adipose-derived mesenchymal precursor cell (haMPC) indicated for the treatment of knee osteoarthritis. The cells are aspirated from patients by liposuction.
The treatment reduced pain, improved function and flexibility of the knee, and increased walking distance. No severe adverse events have been report in association with its use.
Read More
The sponsor has not provided information on the cells.
Read More
Product Information for
ReJoin(TM), adipose-derived mesenchymal precursor cell for knee osteoarthritis
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access